The Use of Infliximab to Control Recurrent Cytokine Storms in EBV-Associated Angioimmunoblastic Lymphoma and Hemophagocytic Syndrome
Blood - United States
doi 10.1182/blood.v120.21.4887.4887
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2012
Authors
Publisher
American Society of Hematology